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Abstract
Background: Death from bacterial meningitis is rarely attributed to the actual event causing death.
The present study therefore categorized and characterized the cause and time of death due to bacterial meningitis.
Methods: In a cohort of patients > 15 years of age with community acquired bacterial meningitis the medical
records were reviewed, and a clinical cause of death categorized into six main categories: 1) CNS complications, 2)
Systemic complications, 3) Combination of systemic and CNS complications, 4) Sudden death, 5) Withdrawal of
care, or 6) Unknown.
Results: We identified 358 patients of which 84 (23%) died in-hospital. Causes of death were ascribed to CNS
complications in 43%, Systemic complications in 39%, Combined CNS and systemic complications in 4%, Sudden
death in 7% and withdrawal of care in 5%. Brain herniation, circulatory failure, intractable seizures and other brain
injury were the most common specific causes of death within 14 days from admission (55%).
Conclusion: Fatal complications due to the primary infection – meningitis - is most common within 14 days of
admission. The diversity of complications causing death in meningitis suggest that determining the clinical cause of
death is essential to the evaluation of novel treatment strategies.
Keywords: Bacterial meningitis, Cause of death, Systemic complications, Central nervous system complications,
Sepsis, Brain herniation
Background
Despite advances in clinical care, bacterial meningitis re-
mains a severe disease with a high risk of complications
that may lead to death or severe sequelae [1]. These
complications can be classified as systemic or local
hence referring to shock, respiratory failure, organ fail-
ure, coagulation disorders or the intracranial complica-
tions stroke, seizures or brain herniation [2]. Yet, death
from meningitis is rarely attributed to a diagnosed or
suspected complication.
Previous studies have identified that systemic disease
complications - septicemia and respiratory failure - was
the primary cause of death among elderly patients with
bacterial meningitis whereas local complications to the
brain infection, i.e. brain herniation, dominates among
younger patients [3, 4]. Also, it has been suggested that
causes not directly related to meningitis are responsible
for late deaths more than 2 weeks after admission,
whereas fatal outcome before day 14 is more likely to be
attributed to meningitis and complications related to
meningitis [5].
A recent study in patients with septicemia identified
different sepsis profiles based on individual organ failure
complications [6]. These profiles were closely related to
the response to fluid resuscitation and case fatality rate.
Similarly, determining the cause of death in patients pre-
senting with acute bacterial meningitis could improve
the interpretation of clinical studies and the identifica-
tion of risk factors. The present study therefore aimed to
determine the causes and time of death due to meningi-
tis in a population-based cohort.
Method
Setting and study population
We included patients diagnosed with community ac-
quired bacterial meningitis from January 1. 1998 to 31.
12.2014. from the University Hospital in the North Jut-
land Region and from January 1. 2003 to 31.12.2014
from two university hospitals in the Capital Region of
Denmark as described previously [7].
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Patients were eligible to be included if the following
inclusion criteria were fulfilled: Patients were older
than 15 years of age, had a clinical presentation strongly
suggesting bacterial meningitis (headache, fever, stiff-
ness of the neck, petechiae, confusion or impaired level
of consciousness) and ≥ 1 of the following inclusion cri-
teria [7–9]:
1. Positive cerebrospinal fluid (CSF) culture
2. Positive blood culture and one or more of the
following CSF findings: > 10 leukocytes (× 106 cells/
L); glucose index < 0.23; CSF glucose < 1.9 mmol/L;
protein > 2.2 g/L
3. Presence of bacteria in Gram stain of CSF.
4. Non-culture identification of bacteria in CSF by
either gene amplification or antigen test
Exclusion criteria:
1. Patients with unidentified cause of CSF
inflammation
2. Nosocomial meningitis [10]
3. Patients whose records/files could not be retrieved
Patients were a priori divided into three groups
based on time of death since admission – early (< 48
h), intermediate (3 to 14 days) and late death (> 14
days) [2, 5].
Time of arrival at hospital as noted by ambulance staff,
nurses or secretaries in the Emergency Department was
used for calculation of time to antibiotic therapy for bac-
terial meningitis as described elsewhere [7].
Cause of death
Patient files were reviewed by expert infectious disease
specialists in teams of two (CTB, JB, BRH and HN)
whom in the daily clinical work treat patients with cen-
tral nervous system infections. Autopsy results were
available in eight cases. Deaths were categorized to be
caused by either:
1) Central nervous system (CNS) complications
2) Systemic complications
3) Combination of systemic and CNS complications
4) Sudden death
5) Withdrawal of care
6) Cause of death could not be ascertained.
After each primary category had been determined, a
specific diagnosis on the cause of death was assigned. In
case of disagreement on the primary cause of death, a
third clinical expert reviewed the case and a final diag-
nosis was established by discussion.
Central nervous system (CNS) complications
Brain herniation
A diagnosis of brain herniation was applied to patients
where a decline in consciousness was observed over
hours combined with pupillary abnormalities and/or sec-
ondary circulatory or respiratory complications.
Brain injury
Brain infarct or brain hemorrhage was only ascertained
as primary cause of death where a terminal event coin-
cided with findings of large brain infarcts or brain
hemorrhage without other apparent reasons for fatal
outcome.
Intractable seizures
This diagnosis was applied to patients in whom max-
imum anticonvulsive therapy including respirator treat-
ment was unable to stop seizure activity or general
twitching.
Global injury / unresponsive
This diagnosis was assigned to patients with brain injury
on imaging or with diminished pupillary reaction who
did not receive sedatives.
Systemic complications
Circulatory failure was determined as cause of death in
cases with hypotension unresponsive to fluid and vaso-
pressor therapy including patients where fatal circulatory
failure led to cardiac arrest. This category represented
cases with a clinical presentation resembling septic
shock.
Respiratory failure was applied as cause of death in pa-
tients with respiratory fatigue, oxygenation problems
also including patient with respiratory failure despite
mechanical respirator treatment.
Other organ failure refers to death related to liver-
failure, kidney-failure or intestinal complications.
Other specified causes of death
Sudden unexpected death was defined by patients con-
sidered to be in a disease recovery phase and expected
to recover for discharge by the treating clinician. Sudden
death due to cardiac arrest in the acute phase of the dis-
ease was as primary group assigned to systemic compli-
cation and sub-categorized as circulatory failure.
Withdrawal of care was the cause of death in cases
were suspected CNS complications, systemic complica-
tions or the combination where left untreated or patients
taken off mechanical ventilator assistance due to other
severe concurrent conditions and comorbidity.
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Statistical analysis
Categorical data are presented as absolute counts and
percentages and, when relevant, compared by Fisher’s
exact test or Chi-square. Continuous data are presented
as median and inter-quartile range (IQR) and compared
using the Kruskal-Wallis test. A Cohens kappa was cal-
culated for the level of agreement between all raters for
the primary and secondary causes of death. Correlation
coefficients was assessed by the following modified
Cohens scale; 0–0.20 = No agreement; 0.21 to 0.39 =
Minimal agreement; 0.40 to 0.59 =Weak agreement;
0.60 to 0.79 =Moderate agreement; 0.80 to 0.9 = Strong
agreement; Above 0.9 = Almost perfect agreement [11].
All calculations were carried out using PRISM 8.
Results
A total of 358 patients with microbiologically confirmed
bacterial meningitis were included in this study. Gender
and age were equally distributed in the population with
179 males (50%) with a median age of 59 (48 to 68) years
and 179 females with a median age of 59 years (50 to
72). Eighty-four patients (23%) died in-hospital. Median
time to death was 8 days (3 to 16.8).
Mortality was unchanged in the study period (1998 to
2007: 22.2% and 2007 to 2015: 24.5%).
The no. of patients treated with adjunctive dexametha-
sone was not different between survivors and fatal cases
(n = 146 of 274 versus n = 35 of 84, p = 0.08).
Cause and time of death, Table 1 and Fig. 1
A primary cause of death could be ascertained in 82 of
84 patients (98%). Thirty-six patients (43%) died from
CNS complications and 33 patients (39%) died from sys-
temic complications. Fifteen patients (18%) were not
classified into these two categories. Of these; Six patients
(7%) died suddenly and unexpected; Care and treatment
was withdrawn in 4 patients (5%); The cause of death
was assigned to a combination of CNS and systemic
causes in three patients (4%).
Early mortality (< 48 h since admission)
Eighteen patients of 84 (21%) died soon after admission
with causes equally distributed between CNS and
Table 1 The cause and time of death. Categorization of the causes of death into three admission-time categories - early,
intermediate and late death. Specific causes of death are shown below the primary categories
Cause and time of death
among 84 patients
Total n Early time of death 0 to 2 days
from admission
Intermediate time of death 3 to 14
days from admission
Late time of death > 14 days
from admission
84 18 of 84 (21%) 38 of 84 (45%) 28 of 84 (33%)
1. CNS complications 36 of 84
(43%)
8 of 18 (44%) 19 of 38 (50%) 9 of 28 (32%)
Brain herniation 8 6 2 0
Brain infarct 6 0 3 3
Brain haemorrhage 1 0 0 1
Intractable seizures 6 0 6 0
Global brain injury
/unresponsive
11 0 6 5
CNS complications not
further specified
4 2 2 0
2. Systemic complications 33 of 84
(39%)
9 of 18 (50%) 13 of 38 (34%) 11 of 28 (39%)
Circulatory failure /septic
shock
14 7 4 3
Respiratory failure 7 0 2 5
Other organ failure 6 1 4 1
Systemic complications
not futher specified
6 1 3 2









0 of 18 (0%) 3 of 38 (8%) 3 of 28 (11%)
5. Withdrawel of care 4 of 84
(5%)
0 of 18 (0%) 2 of 38 (5%) 2 of 28 (7%)




0 of 18 (0%) 1 of 38 (3%) 1 of 28 (4%)
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systemic complications (8 and 9 patients respectively).
One patient was classified with combined CNS and sys-
temic complications as the cause of death (Table 1).
Brain herniation and circulatory failure were the spe-
cific causes of death in 13 of 18 (72%) patients dying
within 2 days of admission.
Intermediate mortality (3 to 14 days after admission)
Thirty-eight of 84 patients (45%) died in this time inter-
val. A CNS complication was the primary cause of death
in 19 patients (50%) and systemic complications in 13
(34%). Sudden unexpected death, withdrawal of care and
undetermined cause of death was observed in six cases
(16%) (Table 1).
Late mortality (> 14 days after admission)
Twenty-eight of 84 patients (33%) died late during ad-
mission. CNS complications, systemic complications and
the combined outcome of CNS and systemic complica-
tions was responsible for fatal outcome in eight (29%),
12 (43%) and two (7%) patients, respectively. Sudden un-
expected death occurred in three patients (11%) and care
was withdrawn in two patients (7%).
Brain herniation, global brain injury, intractable sei-
zures and circulatory failure was determined cause of
death in 31 of 56 patients (55%) dying within 14 days,
Table 1.
Interrater agreement
The level of agreement between all raters was substantial
with a kappa 0.61 for primary classification of cause of
death and 0.53 for the secondary subclassification.
Fatal CNS and systemic complications – patient
comparisons
Fatal CNS complications, Table 2
Clinically, patients with fatal outcome due to a CNS
complication were older than survivors. The proportion
of patients with a Glasgow Coma Score (GCS) below 9
as well as the proportion of patients with focal neuro-
logical deficits were higher among patients with fatal
CNS complications (17 of 36 (47%) vs. 47 of 274 (18%),
p < 0.0001) and (11 of 36 (21%) vs. 25 of 274 (9%), p =
0.0006) compared to survivors. Heart rate/pulse was sig-
nificantly higher on admission compared to survivors
(106 (88 to 120) vs. 95 (84 to 110), p = 0.022). Blood and
CSF biochemistry was not different comparing patients
dying from CNS complications to survivors.
Brain pathology visualized on brain imaging was sig-
nificantly more common among patients dying from
CNS complications than among survivors (23 of 36
(64%) vs. 62 of 274 (23%), p < 0.0001).
Microbiology. S. pneumoniae was the most common
causative organism in patient dying from CNS complica-
tions but not different to survivors (25 of 36 (69%) vs.
149 of 274 (54%), p = 0.11). No cases of meningitis due
to N. meningitidis died from CNS complications.
Fig. 1 Time from admission to death. At 7 days from admission 41 of 84 patients were dead (49%). Within 14 days of admission 56 patients (66%)
had died. Median time to death was 8 days (3 to 16.8)
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Fatal systemic complications, Table 2
Clinically, the heart rate/pulse was significantly higher
on admission in patients dying from systemic complica-
tions compared to survivors (105 (92 to 130) vs. 95 (84
to 110), p = 0.0022).
Otitis media or sinusitis as focus of infection was sig-
nificantly less common among patients dying from
systemic complications compared to survivors (2 of 33
(6%) vs. 73 of 274 (27%), p = 0.026).
Blood and CSF biochemistry data showed significantly
decreased levels of blood leukocytes and thrombocytes
among patients dying from systemic complications com-
pared to survivors (leukocyte count 14.2 × 109 cells/L
(9.2 to 19.0) vs. 17.6 (12.6 to 23.9), p = 0.035), and
Table 2 Baseline characteristics of patient with bacterial meningitis. Demographics-, clinical-, biochemical-, brain pathological- and
causative pathogen data in 274 survivors from bacterial meningitis and 84 patients dying from bacterial meningitis







n = 274 n = 84 n = 33 n = 36
Age (years) 56 (44 to 66) 69 (57 to 78) 67 (52 to 76)a 69 (54 to 77)a 0.0002
Male sex 145 (53%) 33 (40%) 13 (39%) 15 (42%) 0.08
Admission days 16 (12 to 28) 8 (3 to 16.8) 9 (2 to 16) 6 (3 to 14.8) ND
Clinical findings
Seizures before or on admission 28 (10%) 5 (6%) 1 (3%) 2 (6%) 0.33
Glasgow Coma Scale score < 9 (GCS) 47 (18%) 30 (37%) 6 (18%) 17 (47%)a < 0.0001
Focal neurological deficits on
admission
25 (9%) 19 (23%) 6 (18%) 11 (31%)a 0.0006
Focus of infection (otitis media/sinuitis) 73 (27%) 14 (17%) 2 (6%)a 7 (19%) 0.026
Focus of infection (pneumonia) 34 (12%) 15 (18%) 4 (12%) 7 (19%) 0.49
Systolic blood pressure on admission
(mmHg)
138 (122 to 158) 135 (110 to 161) 120 (90 to 144)a 142 (121 to 180) 0.0023
Pulse rate (beats/minute) 95 (84 to 110) 106 (90 to 128) 105 (92 to 130)a 106 (88 to 120)a 0.0022
Laboratory results
B-leucocytes (109/L), n = 332 17.6 (12.6 to 23.9) 15 (9.9 to 20) 14.2 (9.2 to 19.0)a 15.0 (11.0 to 25.0) 0.035
B-thrombocytes (109/L), n = 307 208 (145 to 273) 149 (73 to 244) 103 (57 to 203)a 206 (111 to 311) < 0.0001
B-creatinine (mmol/L), n = 318 78 (63 to 100) 100 (77 to 190) 162 (76 to 227)a 91 (68 to 118) 0.0003
Cerebrospinal fluid-leucocytes
(106/L), n = 346
2653 (660 to 6152) 947 (165 to 5754) 600 (164 to 4976) 1040 (160 to 6229) 0.052
Cerebrospinal fluid-protein (g/L), n = 323 3.6 (1.9 to 6.5) 5.2 (1.4 to 8.7) 2.6 (0.7 to 7.6) 5.9 (2.4 to 8.8) 0.13
Brain imaging pathology
No. of patients with brain imaging pathology 62 (23%) 35 (42%) 9 (27%) 23 (64%)a < 0.0001
Brain infarction or haemorrhage 24 (9%) 21 (24%) 7 (21%) 14 (39%)a < 0.0001
Brain hydrocephalus 5 (2%) 5 (6%) 0 (0%) 5 (14%)a 0.0002
Brain edema 15 (5.5%) 7 (8%) 1 (3%) 5 (14%) 0.10
Microbiology
Patients with positive blood culture 150 (55%) 54 (64%) 23 (70%) 23 (66%) 0.18
Streptococcus pneumoniae 149 (54%) 45 (54%) 9 (27%) 25 (69%) 0.11
Neisseria meningittidis 54 (20%) 5 (6%) 5 (15%) 0 (0%)a 0.0009
Staphylococcus aureus 8 (3%) 13 (15%) 8 (24%)a 5 (14%) < 0.0001
Listeria monocytogenes 18 (7%) 8 (10%) 4 (12%) 2 (6%) 0.47
Other streptococci 18 (7%) 8 (10%) 6 (18%)a 1 (3%) 0.27
Other gram negative bacteria 21 (8%) 5 (6%) 1 (3%) 3 (8%) 0.63
aKruskal-Wallis test (medians with quartiles) or Fishers exact test, signicantly different comparing fatal outcome due to systemic and CNS complications to the
group of survivors
ND Not Determined
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thrombocyte count 103 × 109 cells/L (57 to 203) vs. 208
(145 to 273), p < 0.0001). Blood creatinine levels were
significantly increased in patients dying from systemic
complication compared to survivors (162mmol/L (76 to
227) vs. 78 (62 to 100), p = 0.0003). Cerebrospinal fluid
(CSF) leukocyte count was borderline significantly lower
among patients dying from systemic complications com-
pared to survivors (600 × 106 cells/L (164 to 4976) vs.
2653 (660 to 6152), p = 0.052).
Brain pathology visualized on brain imaging was not
different comparing patients dying from systemic com-
plications to survivors.
Microbiology. Among patients dying from systemic
complications, infection due to S. aureus was more com-
mon than among survivors (8 of 33 (24%) vs. 8 of 274
(3%), p < 0.0001).
Clinical-, biochemical-, brain imaging-, and microbio-
logical data for the most common specific causes of
death within 14 days of admission are shown in Table 3.
The cause of death according to GCS on admission
are shown in Table 4.
The proportion of patients presenting with uncon-
sciousness (GCS < 9) was higher among patient dying
from CNS complications compared to patients dying
from systemic complications (17 of 30 (57%) versus 6 of
30 (20%), p = 0.011). In total only 7 patients dying from
meningitis presented with GCS 15 (9%).
Timing of antibiotic therapy was subject to an equal
delay among patient dying from CNS or systemic com-
plications (median 4.4 versus 5.3 h, p = 0.65), Table 5.
Among patients dying from CNS complications patients
dying from brain herniation was treated most urgently
whereas patients dying from brain infarction was subject
to the greatest treatment delay (ns).
Discussion
In the present study, we evaluated the causes and timely
occurrence of death in bacterial meningitis in adults. We
identified a wide spectrum of complications ranging
from brain edema and vascular injury to circulatory- and
respiratory failure. Our findings corroborate that assign-
ing death only to meningitis is a crude measure.
We were able to categorize the cause of death in 82 of
84 cases. Sixty-nine of 82 cases were categorized into two
main causes of death - CNS and systemic complications.
Among patients dying within 48 h of admission, 13 of
18 patients (72%) died from two distinct acute meningi-
tis complications – brain herniation or circulatory failure
due to septic shock.
Meningitis patients categorized as dying from systemic
complications presented with a clinical appearance, blood
biochemistry, microbiological findings and brain path-
ology different to survivors and patients dying from CNS
complications. Also, the proportion of patients presenting
with low GCS on admission was high among patient dying
from CNS complications whereas patient dying from sys-
temic complications less commonly presented with un-
consciousness (Table 4). Despite the very different clinical
and paraclinical presentations, patient dying from CNS
complications did not receive more prompt treatment for
bacterial meningitis except for those with early fatal dis-
ease caused by brain herniation. These findings, that es-
sentially depict the characteristics of septicemia versus
classical meningitis pathology, may not be a surprising
result.
The very different courses of disease that lead to death
from meningitis emphasize the need for a nuanced view
on fatal cases. Categorizing the cause of death as well as
characterizing each case has also been suggested in studies
of the cause of death from sepsis [12–14]. The goal is to
be able to prevent complications and to improve the valid-
ity of clinical trials by improving study homogeneity.
Two previous studies by Weisfelt et al. [2, 3] investi-
gated the cause of death from bacterial meningitis and
more specifically pneumococcal meningitis. Our results
concerning categorization of the cause of death and dis-
tribution between systemic and CNS complications
causing of death are very similar. Also, Weisfelt et al.
showed that brain herniation is primarily observed
among younger patients which we believe agrees with
our findings (Table 3). Only did Weisfelt et al. find that
more patients with pneumococci died from systemic
causes where pneumococci in our study was the primary
cause of CNS complications.
CNS complications represented 43% of the total causes
of death. Most fatal cases due to CNS complications
(75%) was observed within 14 days of admission. This is
in agreement with the results by McMillan et al. [5],
who found that death due to the meningeal infection it-
self was less likely to occur more than 14 days after ad-
mission. After 14 days, systemic complications that were
more likely due to secondary infections, were also more
common in our cohort (Table 1). The timely distribution
of death in our population was almost identical to the
findings in the study by McMillan et al. (Fig. 1).
Previously identified prognostic factors for poor out-
come from meningitis in adults are advanced age, low
GCS on admission, positive blood culture, low CSF
leukocyte count, elevated CSF protein and immunosup-
pressive comorbidity including alcoholism [15–17]. Also,
neurological deficits and presence of seizures on admis-
sion are indicators of a poor prognosis [18]. These pa-
rameters cannot be translated into treatment strategies
improving the course of disease albeit knowledge of in-
creased risk of meningitis among certain groups could
led to early empiric treatment or prevention with vac-
cines [7]. Even though speculative, the clinical, biochem-
ical and brain imaging description of patients dying
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from bacterial meningitis could be very important for
the discovery of modifiable factors that could improve
outcome due to early identification of patients at risk.
Similar considerations have previously been published in
the field of septicemia as referenced above.
The present study has obvious limitations due to the
retrospective data-collection. The presented data are
dependent on the attending physician’s description of the
disease and its complications. Even though patients were
admitted to departments specialized in the treatment and
care for patients with bacterial meningitis the level of de-
tail in the medical records varied. The few autopsies
performed did only support the clinical diagnosis and pre-
vious autopsy studies in patients dying from sepsis or
meningitis have not identified the cause of death but have
provided vital information of the organ injury [19, 20]. In
that respect we believe that the cause of death analysis
performed by clinical experts must be second best to the
combination of autopsy and clinical case evaluation.
In a rather large proportion of our patients (21%) we
were unable to determine a more specific diagnosis as
the cause of death which may pose a significant problem
to the timely assessment of cause of death. Among the
group of patients where we were unable to provide a
Table 3 Baseline demographics-, clinical-, biochemical-, brain pathological- and causative pathogen data for the 4 most prevalent
specific causes of death occurring within 14 days from admission
Baseline characteristics of patients dying
from bacterial meningitis
Brain herniation Global brain injury /unresponsive Intractable seizures Circulatory failure
n = 8 n = 11 n = 6 n = 14
Age (years) 52 (38 to 75) 68 (54 to 74) 70 (62 to 83) 55 (47 to 69)
Male sex 2 (25%) 4 (36%) 4 (67%) 4 (29%)
Survival days 2 (1 to 2.8) 10 (6 to 18) 4.5 (3.8 to 5.8) 3 (1.8 to 16.8)
Clinical findings
Seizures before or on admission 0 (0%) 0 (0%) 1 (17%) 1 (7%)
Glasgow Coma Scale score < 9 (GCS) 4 (50%) 7 (64%) 2 (34%) 3 (21%)
Focal neurological deficits on admission 2 (25%) 3 (27%) 1 (17%) 4 (29%)
Focus of infection (otitis media/sinuitis) 3 (38%) 2 (18%) 0 (0%) 0 (0%)
Focus of infection (pneumonia) 2 (25%) 2 (18%) 2 (33%) 2 (14%)
Systolic blood pressure on admission
(mmHg)
145 (120 to 181) 172 (120 to 210) 160 (122 to 170) 106 (84.5 to 122.8)
Pulse rate (beats/minute) 83 (78 to 128) 110 (103 to 129) 102 (86 to 120) 130 (93 to 186)
Laboratory results
B-leucocytes (109/L) 18.3 (8.9 to 24.5) 16.5 (12.8 to 26.9) 11.6 (7.7 to 25.0) 15.7 (6.4 to 20.5)
B-thrombocytes (109/L) 183 (101 to 286) 304 (128 to 452) 208 (167 to 238) 99 (68 to 201)
B-creatinine (mmol/L) 75 (63 to 90) 69 (52 to 102) 112 (95 to 141) 197 (95 to 247)
Cerebrospinal fluid-leucocytes (106/L) 2742 (474 to 54.800) 1040 (741 to 4330) 932 (115 to 5326) 558 (75 to 4566)
Cerebrospinal fluid-protein (g/L) 4.6 (2.8 to 9.9) 6.1 (2.1 to 9.1) 5.5 (3.6 to 7.2) 1.9 (0.6 to 15.9)
Brain imaging pathology
No. of patient with brain imaging
pathology
7 (88%) 8 (72%) 0 (0%) 3 (23%)
Brain infarction or haemorrhage 1 (13%) 6 (55%) 0 (0%) 2 (15%)
Brain Hydrocephalus 2 (25%) 3 (27%) 0 (0%) 0 (0%)
Brain edema 5 (63%)* 0 (0%) 0 (0%) 0 (0%)
Microbiology
Patients with positive blood culture 5 (63%) 6 (55%) 4 (67%) 11 (79%)
Streptococcus pneumoniae 6 (75%) 7 (64%) 5 (83%) 4 (29%)
Neisseria meningittidis 0 (0%) 0 (0%) 0 (0%) 3 (21%)
Staphylococcus aureus 0 (0%) 2 (18%) 0 (0%) 4 (29%)
Listeria 0 (0%) 1 (9%) 1 (17%) 0 (0%)
Other streptococci 0 (0%) 1 (9%) 0 (0%) 3 (21%)
Other gram negative bacteria 2 (25%) 0 (0%) 0 (0%) 0 (0%)
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more specific diagnosis than CNS complications and the
group suggested to have global brain injury/unrespon-
sive state may have suffered an unregistered critical
event including subtle signs of brain herniation/edema
or a period with circulatory insufficiency. Also, the rater
could be biased towards a diagnosis of a CNS complica-
tion in patients with an unresponsive state after several
days or weeks in hospital care. Eventually, there is a risk
Table 4 Cause of death and GCS level on admission. Data was available for 82 of 84 patients. The no. of patients presenting with a
GCS < 9 was significantly higher among patients dying from CNS complications than among patients dying from systemic
complications (p = 0.011)
GCS < 9 GCS 9–12 GCS 13–14 GCS 15
Data available for 82 of 84 patients 30 of 82 (37%) 29 of 82 (35%) 16 of 82 (20%) 7 of 82 (9%)
1. CNS complications 17 of 30 (57%) 9 of 29 (31%) 7 of 16 (44%) 2 of 7 (29%)
Brain herniation 4 3 0 1
Brain infarct 1 3 1 0
Brain haemorrhage 1 0 0 0
Intractable seizures 2 1 2 1
Global brain injury /unresponsive 7 0 4 0
CNS complications not further specified 2 2 0 0
2. Systemic complications 6 of 30 (20%) 15 of 29 (52%) 8 of 16 (50%) 4 of 7 (57%)
Circulatory failure /septic shock 2 6 2 3
Respiratory failure 0 5 2 0
Other organ failure 0 1 2 0
Systemic complications not futher specified 4 3 2 1
3. Combined CNS and systemic causes 2 of 30 (7%) 0 of 39 (0%) 1 of 16 (6%) 0 of 7 (0%)
4. Sudden unexpected death 3 of 30 (10%) 2 of 29 (7%) 0 of 16 (0%) 0 of 7 (0%)
5. Withdrawel of care 2 of 30 (7%) 1 of 29 (7%) 0 of 16 (0%) 1 of 7 (14%)
6. Unable to determine cause of death 0 of 30 (0%) 2 of 29 (7%) 0 of 16 (0%) 0 of 7 (0%)
Table 5 Cause of death and timing of appropriate antibiotic treatment for bacterial meningitis. Data was available for 74 of 84
patients. No significant differences in time to treatment for bacterial meningitis was found (Kruskal-Wallis test, p > 0.05)
Time to treatment for bacterial meningitis 0 to 2 h 2 to 6 h > 6 h
Data available for 74 of 84 patients Hours (median and quartiles) 23 of 74 (31%) 16 of 74 (22%) 35 of 74 (47%)
1. CNS complications (n = 32) 4.4 (1.3 to 22.4) 11 of 23 (48%) 6 of 16 (38%) 15 of 35 (43%)
Brain herniation (n = 7) 1.0 (0.5 to 8.6) 5 0 2
Brain infarct (n = 5) 25.0 (5.2 to 52.5) 1 0 4
Brain haemorrhage (n = 1) 2.0 1 0 0
Intractable seizures (n = 6) 11.0 (2.3 to 31.0) 1 2 3
Global brain injury /unresponsive (n = 9) 10.5 (3.3 to 34.8) 1 2 6
CNS complications not further specified (n = 4) 2.4 (1.3 to 4.5) 2 2 0
2. Systemic complications (n = 28) 5.3 (1.9 to 21.5) 7 of 23 (30%) 8 of 16 (50%) 13 of 35 (37%)
Circulatory failure /septic shock (n = 10) 8.2 (1.0 to 40.8) 3 1 6
Respiratory failure (n = 7) 6.0 (3.5 to 20.0) 1 3 3
Other organ failure (n = 2) 9.5 (1.0 to 18.0) 1 0 1
Systemic complications not futher
specified (n = 9)
3.9 (1.9 to 18.2) 2 4 3
3. Combined CNS and systemic causes (n = 3) 1.3 (0.6 to 4.5) 2 of 23 (9%) 1 of 16 (6%) 0 of 35 (0%)
4. Sudden unexpected death (n = 5) 18.0 (1.9 to 39.0) 1 of 23 (4%) 1 of 16 (6%) 3 of 35 (9%)
5. Withdrawel of care (n = 4) 4.2 (0.9 to 20.0) 2 of 23 (9%) 0 of 16 (0%) 2 of 35 (6%)
6. Unable to determine cause of death (n = 2) 25.1 (24.0 to 26.3) 0 of 23 (0%) 0 of 16 (0%) 2 of 35 (6%)
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that these patients were wrongly labelled due to the
retrospective clinical evaluation.
Our interrater agreement is comparable to other previ-
ous studies and we find the agreement to be acceptable
[2, 14]. The review of cases with disagreement with a
third expert resulted in full agreement.
Conclusion
The cause of death from meningitis is very diverse but
can on a superior level be divided into local CNS- or
systemic complications. CNS complications present with
abnormal brain imaging in 2/3 of cases and are most
commonly caused by pneumococci. Systemic complica-
tions are primarily circulatory failure presenting with
clinical and biochemical sepsis. Death related to the pri-
mary infection – meningitis – occur most commonly
within 14 days from admission.
Determining the cause of death from meningitis
should be a priority in the evaluation of clinical trials.
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